Study | Design | nd | Mean Age (Age range), years | Sinuses dilated via balloon | Inclusion | Adjunct procedure(s) | Follow-up time | Efficacy (by SN-5) Mean (SD) | Efficacy (by others) Mean (SD) | Revision, antibiotics use and AEs |
---|---|---|---|---|---|---|---|---|---|---|
Ramadan HH et al. 2010a [35] | Prospective interventional non-randomized | 30 (55 sinuses) | 6.6 (2–11) | 48 Maxillary 2 Frontal 5 Sphenoid | Chronic sinusitis (> 3 months or 6 episodes per year) AND 2 failed courses of antibiotics AND positive CT scan | Adenoidectomy (n = 17) | 52 weeks | Preop: 4.2, Postop: 3; 24 (80%) improveda | NR | Second intervention by ESS (2); AEs: NR |
Ramadan HH et al. 2010b [36] | Prospective single arm cohort | 24 (56 sinuses) | 6.5 (2–11) | 50 Maxillary 2 Frontal 4 Sphenoid | Refractory CRS which failed medical treatment AND evidence of CRS on CT scan | Adenoidectomy (n = 15); Ethmoidectomy (n = 6) | 52 weeks | Preop: 4.9 (1.14), Postop: 2.95 (1.35); 21 improveda | NR | AEs: None |
Ramadan HH et al. 2012 [28] | Prospective single arm cohort | 26 (33 sinuses) | 7.7 (4–12) | 33 Maxillary | Chronic sinusitis (> 3 months or 6 episodes per year) after failed adenoidectomy AND positive CT findings. | Ethmoidectomy (n = 4); Maxillary antrostomy (n = 3); Revision adenoidectomy (n = 2) | 52 weeks | Preop: 4.6 (0.9), Postop: 3 (1.2); 21 (81%) improveda | NR | AEs: None |
Thottam PJ et al. 2012 [30] | Retrospective, two group cohort blinded | 15 (40 sinuses) | 9.3 (3–17) | 30 Maxillary 10 Frontal | Refractory CRS (at least 90 days despite medical therapy) AND CT confirmed uncomplicated CRS with the presence of maxillary +/− frontal sinus disease. | Ethmoidectomy | > 4 months (average of 37 weeks) | SN-5: NR; 12 (80.0%) Improvedb | NR | Second intervention by ESS (1); Off Antibiotic: 11 (73.3%); AEs: None |
Wang F et al. 2015 [29] | Prospective interventional non-randomized controlled | 42 | 9.3 (7–12) | Maxillary and Frontalc | Diagnosis of CRS according to EPOS 2012. Refractory CRS (defined as at least 2 years despite medical therapy) | Adenoidectomy | 1 year | Preop: 4.3 (0.9), Postop: 2.9 (0.8); 39 (92.9%) improveda | VAS Preop: 5.2 (1.4), Postop: 3.1 (1.6) | AEs: periorbital swelling (1) |
Thottam PJ et al. 2016 [31] | Retrospective, two group cohort | 13 (34 sinuses) | 9.3 (3–18) | 26 Maxillary 8 Frontal | Refractory sinus symptoms despite medical treatments AND CT scan confirmed uncomplicated CRS and the presence of maxillary sinus disease with a Lund-Mackay score greater than 5. | Ethmoidectomy | 2 years | SN-5: NR; 10 (76.9%) Improvedb | NR | Second intervention by ESS (1); AEs: NR |
Soler ZM et al. 2017 [24] | Prospective single arm cohort | 33 | 6.6 (2–12) | Maxillary, Frontal and Sphenoidc | Diagnosis of CRS according to EPOS12, positive CT findings and disease resistant to medical treatments. | Adenoidectomy (n = 19); Inferior turbinate reduction (n = 6); Ethmoidectomy (n = 4); Tonsillectomy (n = 5); Others (n = 4) | 6 months | Preop: 4.8 (1.2), Postop: 1.7 (0.8); 32 (97%) improveda | NR | Second intervention (0); AEs: None |
Liu J et al. 2017 [25] | Prospective single arm cohort | 30 (61 sinuses) | 10.2 (6–15) | 38 Maxillary 9 Frontal 14 Sphenoid | Confirmed by positive Nasal endoscopy and CT scan AND failed Medical management for at least 3 months | None | 12 months | Preop: 23.04 (12.47), Postop: 1.07 (2.11) | Lund-Mackay score Preop: 12.29 (6.23), Postop: 1.39 (2.47); VAS Preop: 17.86 (7.59), Postop: 0.57 (1.60); Endoscopic score of Lund-kennedy preop: 6.69 (3.07), postop: 0.36 (1.89) | AEs: synechia (3) |
Gerber ME et al. 2018 [32] | Randomized controlled blinded study | 12 | 7 | Maxillaryc | CRS with at least 12 weeks of two symptoms AND refractory to medical treatments AND recurrence (4 or more episodes per year) AND evidence of rhinosinusitis on CT scan. | Adenoidectomy with maxillary sinus irrigation (all patients) | 12–18 months | Preop: 3.62 (1.24), Postop: 2.40 (1.11) | NR | NR |
Zalzal HG et al. 2019 [33] | Retrospective single arm cohort | 38 | 6.76 | Maxillaryc | CRS with at least 90 days of 2 or more of symptoms, or endoscopic signs AND failure of medical treatment defined by EPOS 2012 AND previous adenoidectomy AND Lund-Mackay score of at least 5 AND maxillary sinus involvement. | None | 5 years | SN-5: NR | NR | Second intervention by ESS: 5 (13.1%); Off antibiotic: 26 (68.4%) |